⚠️ Half of commercial antibodies miss their target!
So how do you pick the right one for your experiment?

Here’s the solution 👉
Antibody characterization data (all tested in KO cells) are now available at:
🔗 onlygoodantibodies.co.uk

Tested by @ycharos.bsky.social & @oga-community.bsky.social

For our #flowcytometry peeps, would you like to have a single fix/perm protocol that is optimised for everything? One that preserves fluorophores while allowing simultaneous TF and cytokine staining? How about 100-fold cheaper?

You got it:
currentprotocols.onlinelibrary.wiley.com/doi/10.1002/...

🚀 Excited to share our latest publication!
👉 www.nature.com/articles/s41...
A fantastic collaboration with an incredible team.

#BreastCancer #Neutrophils #TumorMicroenvironment #PARPinhibitors #DNARepair #NatureCommunications #CancerImmunology #CalcinottoLab

I am grateful to co-lead authors Laszlo Halasz and Eva Hadadi, and everyone involved from the labs of Jo Van Ginderachter, Laszlo Nagy, and Damya Laoui (@laouimmunology.bsky.social‬).

Our new paper is out:
Tumors don’t just reprogram monocytes locally. We show in a mouse model that the systemic impact of a tumor can alter the epigenome of peripheral monocytes, repressing IFN-responsive regulatory elements and priming pro-tumor gene programs.

Happy to share that I’ll be starting my lab as a junior group leader at the Georg-Speyer-Haus in Frankfurt in 2026. We’ll study how transcriptional regulators control neutrophil function in cancer. I’ll be hiring soon (PhD/lab tech), please reach out if you know someone interested!

Congratulations Santiago!

🚨We're hiring! We've opened a fully-funded Ph.D. position to join my lab at the #LIH, if you are interested in understanding how genetic variation influences immune responses against cancer, don't hesitate to apply! 🔬 🧪

More info below ⬇️
www.lih.lu/en/job/?valu...

#cancer #immunology #genomics